Xylem FY 2025 operating income rises 21.2% to USD 1.2 billion

Reuters02-26
Xylem FY 2025 operating income rises 21.2% to USD 1.2 billion

Xylem reported FY 2025 revenue of USD 9.0 billion (+5.5%), with operating income of USD 1.2 billion (+21.2%) and operating margin of 13.5% (up 170 basis points). Net income attributable to shareholders was USD 957 million (+7.5%), or USD 3.92 per diluted share (+7.4%). On an adjusted basis, net income attributable to shareholders was USD 1.2 billion (+19.0%), or USD 5.08 per diluted share. FY 2025 adjusted EBITDA was USD 2.0 billion (+14.0%), with an adjusted EBITDA margin of 22.2% (up 160 basis points). Operating cash flow was USD 1.2 billion (-2.0%) and free cash flow was USD 910 million (-3.0%). Orders were USD 8.9 billion (+2.0%), while total backlog was USD 4.6 billion at December 31, 2025 (-9.0%), with Xylem expecting more than 60% of that backlog to convert to revenue in 2026. By segment in FY 2025, revenue was USD 2.6 billion in Water Infrastructure (+3.2%), USD 1.8 billion in Applied Water (+3.1%), USD 2.1 billion in Measurement and Control Solutions (+11.5%), and USD 2.5 billion in Water Solutions and Services (+5.2%). Xylem said FY 2025 performance reflected organic growth across all segments and most major regions, with organic growth in the U.S. and western Europe more than offsetting organic declines in emerging markets, and highlighted productivity savings and price realization as key contributors to margin expansion. The company also noted restructuring actions in 2025 aimed at simplifying the organization, delivering approximately USD 29 million of savings in FY 2025 and targeting annual future net savings of approximately USD 80 million to USD 120 million beginning in 2026. For FY 2026, Xylem forecast total revenue growth of 1% to 3%, including organic revenue growth of 2% to 4%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xylem Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001524472-26-000012), on February 25, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment